Table 4 Descriptive measures of sonograghic size and status, sonograghic count, sign and symptom, follow-up distance, recurrence, metastasis/sarcoma, Hb, and LDH in the STUMP group

Sonograghic size (cm), n (%)

5–10

9 (50%)

 ≥ 10

9 (50%)

Sonograghic myoma status, n (%)

Myoma

12 (66.7%)

Non myoma

6 (33.3%)

Sonograghic count, n (%)

Single

6 (33.3%)

Multiple

12 (66.7%)

Sign & symptom, n (%)

AUB

10 (47.6%)

Pelvic pain

5 (23.8%)

Mass sensation

3 (14.3%)

Infertility

3 (14.3%)

Follow up (month), n (%)

 < 12

6 (30%)

12–36

6 (30%)

36–120

6 (30%)

 > 120

2 (10%)

Recurrence, n (%)

Yes

4 (20%)

No

16 (80%)

Metastasis/ sarcoma, n (%)

Yes

2 (10%)

No

18 (90%)

Hb (mg/dl), n (%)

 < 12

12 (57.1%)

12–16

9 (42.9%)

LDH (IU), n (%)

 > 480

1 (4.8)

 ≥ 480

20 (95.2%)